简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-05-05 14:15 AleAlentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officercer
2022-05-05 13:29 Groundbreaking research cooperation: The Medi-Globe Group and the IHU in Strasbourg are developing the world's first AI software for detecting pancreatic diseases
2022-05-05 08:35 Patient Safety Movement Foundation Announces Winners of 2021 Humanitarian and Lewis Blackman Awards
2022-05-04 21:55 Exscientia to Present at the BofA Securities 2022 Healthcare Conference
2022-05-04 21:49 Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma
2022-04-29 09:55 Press Ganey Advances Technology via Acquisition of Forsta, a Global Leader in Market Research, Customer Experience and Employee Experience
2022-04-29 09:51 Partners Life Becomes First New Zealand Life and Health Insurer To Go Live On The FINEOS Platform
2022-04-28 15:00 Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
2022-04-27 18:46 Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories
2022-04-27 09:25 94th Vifor Pharma Group Annual General Meeting
2022-04-26 13:51 Nissin Foods and Toyota Partner to Realize Well-Being for All Through Food
2022-04-26 11:12 Mawi iSWAB Microbiome-EL Enables Prime Discoveries’ Development of Rapid Extraction-Less COVID Diagnostic Assay
2022-04-26 08:42 First Patent Regarding RPIDD Infectious Disease Liquid Biopsy Technology DNA Library Preparation and Amplification Methods Granted
2022-04-23 00:12 Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay
2022-04-21 16:17 Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses
2022-04-18 14:25 Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and "Stealth" Omicron (BA.2) Variants
2022-04-18 10:11 Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)
2022-04-15 18:47 Advanced Clinical Continues Global Expansion Into Europe With New Office in Switzerland
2022-04-14 10:51 Takeda Announces Completion of Acquisition of Own Shares
2022-04-13 09:56 Top 10 Finalist Nurses Announced for Inaugural Aster Guardians Global Nursing Award

Business Wire Weibo

Press Releases

Latest Releases